Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, the authors have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline, published in Nature reviews. Neurology
, is based on current literature and expert consensus, and has a ten- step structure to facilitate its use in clinical practice.
READ the consensus statement